Philip Morris International Inc. vs AstraZeneca PLC
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Philip Morris International Inc.
$284.1B
μμ #54
AstraZeneca PLC
$302.7B
μμ #50
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Philip Morris International Inc.μ΄(κ°) 2010λ κΉμ§ AstraZeneca PLCμ(λ₯Ό) μΆμνμ΅λλ€
- AstraZeneca PLCμ΄(κ°) 2014λ κΉμ§ Philip Morris International Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Philip Morris International Inc.μ΄(κ°) 2015λ κΉμ§ AstraZeneca PLCμ(λ₯Ό) μΆμνμ΅λλ€
- AstraZeneca PLCμ΄(κ°) 2018λ κΉμ§ Philip Morris International Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Philip Morris International Inc. | AstraZeneca PLC | μ λ |
|---|---|---|---|
| 2026 | $284.1B | $302.7B | AstraZeneca PLC |
| 2025 | $245.5B | $282.2B | AstraZeneca PLC |
| 2024 | $177.6B | $196.9B | AstraZeneca PLC |
| 2023 | $131.8B | $198.1B | AstraZeneca PLC |
| 2022 | $134.5B | $195.3B | AstraZeneca PLC |
| 2021 | $119.6B | $163.9B | AstraZeneca PLC |
| 2020 | $99.0B | $136.9B | AstraZeneca PLC |
| 2019 | $95.5B | $132.8B | AstraZeneca PLC |
| 2018 | $70.6B | $97.9B | AstraZeneca PLC |
| 2017 | $106.5B | $85.9B | Philip Morris International Inc. |
| 2016 | $88.7B | $64.5B | Philip Morris International Inc. |
| 2015 | $81.7B | $76.6B | Philip Morris International Inc. |
| 2014 | $72.0B | $76.2B | AstraZeneca PLC |
| 2013 | $73.6B | $61.7B | Philip Morris International Inc. |
| 2012 | $68.5B | $46.3B | Philip Morris International Inc. |
| 2011 | $62.0B | $42.7B | Philip Morris International Inc. |
| 2010 | $44.3B | $40.3B | Philip Morris International Inc. |
| 2009 | $34.8B | $38.9B | AstraZeneca PLC |
| 2008 | $29.8B | $32.3B | AstraZeneca PLC |